Abstract

BackgroundRecent evidence proved the necessity to improve health care and pain management in newborns. Osteopathic manipulative treatment (OMT) has been largely used to treat painful syndromes as well as term and preterm newborns. Recent studies have demonstrated positive results of osteopathy in reducing length of stay and costs. However, no trials were carried out on pain in newborns. The aim of the present clinical trial is to explore the effectiveness of osteopathic treatment in reducing pain in a sample of preterms.Methods/designA three-armed single blinded placebo-control randomised controlled trial protocol has been designed to primarily evaluate the extent to which OMT is effective in reducing pain in preterms. One hundred and twenty newborns will be enrolled from one tertiary neonatal intensive care unit in central Italy and randomised in three groups: study, sham and control. The study group will be further prospectively randomised in two subgroups: experienced osteopaths and students. All preterms will receive standard medical care. Osteopathic treatment will be applied to the study group only whilst ‘soft touch’ will be administer to the sham group only. Newborns will undergo manual sessions once a week for the entire period of hospitalisation. Blinding will be assured for neonatal staff and outcome assessor. Primary outcome will be the mean difference in baseline score changes of PIPP questionnaire between discharge and entry among the three groups. Secondary outcomes will be: mean difference in length of stay and costs between groups. Statistical analyses will use per-protocol analysis method. Missing data will be handled using last observation carried forward imputation technique.DiscussionThe present single blinded randomised controlled trial has been designed to explore potential advantages of OMT in the management of newborns’ pain. Currently, based on a patient-centred need-based approach, this research will be looking at the benefit of osteopathic care rather than the efficacy of a specific technique or a pre-determined protocol.Trial registrationThe protocol has been registered on ClinicalTrials.gov (NCT02146677) on 20 May 2014.

Highlights

  • Recent evidence proved the necessity to improve health care and pain management in newborns

  • Based on a patient-centred need-based approach, this research will be looking at the benefit of osteopathic care rather than the efficacy of a specific technique or a pre-determined protocol

  • The only tools which have been largely validated in clinical settings are the Behavioural Indicators of Infant Pain Scale [10] and the Premature Infant Pain Profile (PIPP) [11]

Read more

Summary

Discussion

The present single blinded RCT has been designed to explore potential advantages of OMT in the management of newborns’ pain. It will attempt to confirm the effectiveness of OMT on LOSshortening using a larger experimental study design and to corroborate the absence of placebo effects in newborns It will explore potential differences between expert osteopaths and final-year students on the effectiveness of OMT. No osteopathic trial has been carried out in this field attempting to quantify the benefits of OMT in newborns’ pain using rigorous procedures and ‘gold-standard’ methods for clinical trials. This will be the first concrete experimental trial addressing this outcome.

Background
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call